2025 Markey Cancer Center Annual Report
OUR UNWAVERING
COMMITMENT
Director, Markey Cancer Center
At the UK Markey Cancer Center, we make more cancer-free tomorrows possible through today’s discoveries and innovations.
Research is at the heart of every cancer treatment available, and there’s no time to stop now. Every day, Markey researchers look for clues to cancer’s origins and treatments that will lead to cures. As one of only 57 National Cancer Institute (NCI) Comprehensive Cancer Centers in the country, we know it’s our responsibility to find the answers.
Many of the stories we share here reflect on our research and the difference it makes for both Kentuckians and those who will never set foot in the Commonwealth. I think you’ll feel inspired and hopeful when you read this annual report. I know I do.
We have two cancer vaccine clinical trials at Markey using mRNA technology that could change how we treat pancreatic cancer and nonsmall cell lung cancer. We also recently completed a multistate study focused on ways to prevent cervical cancer in women in Appalachia. The NCI funded that project with an $11 million grant. The research could change how we prevent cervical cancer in other areas of the country, too.
The ingenuity and vision of the people at Markey impresses me every day. One scientist uses zebrafish to search for breakthroughs in pediatric cancer. The collective minds of our Molecular Tumor Board find new treatment options for patients with advanced cancers. Our Clinical Trials Bootcamp provides much-needed support for our newest researchers. Another program challenges graduate students and fellows to explain their research in ways laypeople can easily understand.
In a few years, we’ll care for our patients in a new building, one designed to transform cancer care in Kentucky. Our new home, the UK Cancer and Advanced Ambulatory Building, will open in 2028. Many people have contributed their expertise to this project, including doctors, nurses and patients, as well as an architect with a deeply personal connection to cancer.
Markey is Kentucky’s NCI-designated Comprehensive Cancer Center, and the people of the Bluegrass are why we’re here. How we’re here is through research, the driving force behind every cancer treatment available today — and tomorrow.
B. Mark Evers, MD, FACS
Director, UK Markey Cancer Center
![]()
MARKEY CANCER CENTER
2025 ANNUAL REPORT
IN THIS ISSUE
• Annual Report Articles
• Women Strong Awards
• Markey by the Numbers
• Locations & Network
• Awards & Accreditations
• Past Reports
"AT THE UK MARKEY CANCER CENTER, WE MAKE MORE CANCER FREE TOMORROWS POSSIBLE THROUGH TODAY'S DISCOVERIES AND INNOVATIONS"
B. MARK EVERS, MD, FACS
DIRECTOR, MARKEY CANCER CENTER
ANNUAL REPORT ARTICLES
The Kentucky Blueprint
The UK Markey Cancer Center Affiliate Network stands as a premier model of innovation for rural cancer care. And it’s a model that resonates across state lines. When the University of Iowa set out to establish its own statewide network of rural cancer hospitals, they saw Markey not just as a resource, but as the essential blueprint for success.
Continue Reading
A Tiny Fish Could Transform How We Treat Cancer in Kids
A tiny fish with translucent skin could make a big difference in how we treat patients with pediatric cancer — and the research is happening right here at the UK Markey Cancer Center.
Zebrafish are tropical freshwater fish native to South Asia, and they are particularly useful for cancer research, said Jessica Blackburn, PhD, Markey researcher and associate professor of molecular and cellular biochemistry. The fish can offer important insights into cancer biology, which in turn can power the discovery of less toxic and more effective treatments.
Continue Reading
Joining Forces to Save Lives in Appalachia
Cervical cancer rates in Appalachia are some of the highest in the country. Researchers at the UK Markey Cancer Center wanted to change that through Take CARE (Improving Uptake of Cervical Cancer Prevention Services in Appalachia).
This multistate project looked at ways to prevent cervical cancer in an area of the country where women face challenges accessing healthcare and where there are lower rates of screening. It’s the kind of large-scale research that requires years of effort and millions of dollars, and it wouldn’t be possible without federal funding.
Continue Reading
Hope on the Horizon
Two clinical trials underway at the UK Markey Cancer Center have the potential to change the way we treat pancreatic cancer and nonsmall cell lung cancer.
Markey — Kentucky’s National Cancer Institute-designated Comprehensive Cancer Center — is among an elite group of institutions offering groundbreaking new cancer vaccines that use the same mRNA technology behind the COVID-19 vaccines.
Continue Reading
Blending Science & Support to Ease the Treatment Journey
The Oncology Pharmacy team at the UK Markey Cancer Center does so much more than just dispense medications. These highly specialized pharmacists are an integral part of a cancer care team that delivers advanced treatments to make a significant impact on patients’ lives.
Not only do they have deep knowledge and expertise managing complex cancer therapies, but they also provide expert guidance with compassionate leadership. It’s the kind of pharmacy team you’ll only find at Kentucky’s National Cancer Institute-designated Comprehensive Cancer Center.
Continue Reading
Kentucky Voices Resonate in Our Research
It’s not only scientists who make an impact on the vital cancer research happening at the UK Markey Cancer Center. People from all walks of life make a real difference, too.
At Markey, researchers partner with people and organizations in communities throughout Kentucky. These residents contribute unique insights that make research more relevant to people’s lives. And people who sign up to take part in research help speed up new advances for preventing and treating cancer. When researchers and communities work together, we get more breakthroughs and more cancer-free tomorrows.
Continue Reading
Discovering New Ways to Share Science
The ability to communicate research findings is almost as important as the research itself.
When scientists use clear, accessible language, they can inform the public about their research in ways that spur even more discoveries and can be translated into real-world applications and societal benefits.
A recent competition at the UK Markey Cancer Center challenged PhD-level graduate students and postdoctoral fellows to present their research to a general audience and share how it benefits Kentuckians.
Continue Reading
Building Better Cancer Care
Designing the new UK Cancer and Advanced Ambulatory Building was more than a job for architect Andrew Schneider – it was a calling.
An associate and project manager at Champlin | EOP Architecture, Schneider designed parts of the interior and exterior of the 550,000-square-foot facility that will serve as the new home for the UK Markey Cancer Center. Champlin | EOP partnered with HGA Architects from Minneapolis on the design for the building that will open in early 2028.
Continue Reading
Empowering New Researchers
An innovative program at the UK Markey Cancer Center trains and supports the next generation of cancer researchers as they seek to improve patient outcomes and move us closer to a cure.
The Clinical Trials Bootcamp program helps junior faculty grow their ideas from a concept to a research study. Susanne Arnold, MD, the Markey Cancer Center’s first associate director for Clinical Translation, started the bootcamp in 2013. She saw the challenges junior faculty face in creating new clinical studies and wanted to give them the tools and support they need to succeed.
Continue Reading
The Kentucky Blueprint
The UK Markey Cancer Center Affiliate Network stands as a premier model of innovation for rural cancer care. And it’s a model that resonates across state lines. When the University of Iowa set out to establish its own statewide network of rural cancer hospitals, they saw Markey not just as a resource, but as the essential blueprint for success.
MARKEY WOMEN STRONG AWARDS
Two Markey Cancer Center researchers investigating pediatric leukemia and cancer prevention recently received $50,000 Markey Women Strong research grants.
Markey Women Strong is a philanthropic program of the UK Markey Cancer Foundation that supports cancer research. The program is in its ninth year and has awarded over $900,000 in grants. Member philanthropists are primarily women. A group of past grant recipients peer reviews the initial applications.
Markey Women Strong members actively participate in selecting grant recipients by reviewing applications, hearing presentations from applicants and voting on the most promising research projects. The 2026 Markey Women Strong Distinguished Researchers are:
Jessica Blackburn, PhD, researcher and associate professor of molecular and cellular biochemistry: Her award will support her work to develop a diagnostic tool for childhood leukemia, the most common pediatric disease. Current detection methods can be invasive and costly, and they don’t always find low levels of disease. Blackburn’s research is focused on creating a simple, accurate and affordable test that uses a blood draw.
Yasminka Jakubek Swartzlander, PhD, assistant professor of biomedical informatics in the Department of Internal Medicine: Her research focuses on finding personalized strategies to prevent cancer by identifying the earliest molecular changes that seed cancer. She is studying how exposure to radon gas can affect DNA by looking at the genetic information of 1,900 people in Kentucky. She hopes to see whether DNA mutations are more common in people living in high-radon areas. Since radon increases cancer risk, especially lung cancer, this research could help identify nonsmokers who need lung cancer screening.
MARKEY BY THE
NUMBERS
RESEARCH

301
FACULTY Researchers

406
Research Projects

4,096
Clinical Trials Patients Accrued
CLINICAL

5,484
TOTAL CANCER CASES (CY 2024)
![]()
3,807
Inpatient Cancer Encounters

109,910
Outpatient Cancer Encounters
ADVANCING CANCER
CARE TOGETHER
MARKEY LOCATIONS & AFFILIATES
ACROSS KENTUCKY
Markey Cancer Center
Affiliate Network
- AdVent Health Manchester, Manchester
Clark Regional Medical Center, Winchester - Georgetown Community Hospital, Georgetown
- Harlan ARH Hospital, Harlan
- Harrison Memorial Hospital, Cynthiana
- Hazard ARH Regional Medical Center, Hazard
- Highlands ARH Regional Medical Center, Prestonsburg
- Lake Cumberland Regional Hospital, Somerset
- Lexington VA Health Care System, Lexington
- Meadowview Regional Medical Center, Maysville
- Mercy Health — Lourdes Hospital, Paducah
- Middlesboro ARH Hospital, Middlesboro
- Rockcastle Regional Hospital, Mt. Vernon
- St. Elizabeth Healthcare, Edgewood
- Taylor Regional Hospital, Campbellsville
The Medical Center at Bowling Green, Bowling Green - TJ Samson Community Hospital, Glasgow
- Tug Valley ARH Regional Medical Center, South Williamson
- UK King’s Daughters, Ashland
- UK St. Claire, Morehead
Markey Cancer Center
Research Network
- Hazard ARH Regional Medical Center, Hazard
- The Medical Center at Bowling Green, Bowling Green
- Owensboro Health, Owensboro
- UK King’s Daughters, Ashland
- UK St. Claire, Morehead
Markey Cancer Center Locations
- UK Markey Cancer Center, Lexington
- UK Morehead Cancer Treatment Center, Morehead
Markey Cancer Center at Lexington Clinic Locations
- Markey Cancer Center at Lexington Clinic, Lexington
- Markey Cancer Center at Lexington Clinic, Richmond

AWARDS AND ACCREDITATIONS

RECOGNIZED AMONG
THE NATION'S BEST
• Designated as a Comprehensive Cancer Center by the National Cancer Institute
• Accredited by national organizations, such as FACT, CoC and Magnet, among others
• Nationally recognized in cancer by U.S. News & World Report and Newsweek
• Staffed by physicians who are board certified in oncology
• Committed to providing access to groundbreaking treatments through advanced clinical trials




PAST ANNUAL REPORTS
To revisit previous Markey annual reports, visit the annual report archives to read old articles.